Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: donpat who wrote (10945)	8/21/2018 10:50:02 PM
From: Magnus1	Read Replies (3) \| Respond to of 12873

Intellectual Property Protection. Intellectual Property Protection is protection for inventions, literary and artistic works, symbols, names, and images created by the mind. Learn how you can protect your intellectual propertyby using: Patents, Trademarks, Trade Secrets, and Copyrights. ThIs applies to NNVC 's trade secrets: trade se·cret trad 'sekrit/ noun a secret device or technique used by a company in manufacturing its products. As I've said before for NNVC owns the trade secrets (IP) from their manufacturing processes they have developed making viricides in the Nanoviricides manufacturing facility based on the licenses the have acquired from Theracour so far. This is considered IP and of value and worth protecting. For those of you who don't think these trade secret are IP let's say Theracour decides tomorrow to walk in NNVCs facilities and take all the data, knowledge etc...because they think they own any manufacturing IP derived from their patent. I never once said NNVC owns the patents however NNVC does own the manufacturing IP they have developed. This is the interlocking protection Diwan established to protect his invention. In a sense this arrangement gives the manufacturing IP to NNVC however Diwan maintains control through shareholder rights etc...Diwan does get paid both ways, however he stands to gain far more if NNVC succeeds. It isn't a traditional corporate structure but I'm starting to appreciate it more as we endure this endless attack that the perpetrators continually assure us isn't happening. I understood that Gene had hoped to be the one to get NNVC through the first trial but it didn't work out. NNVC now has a new CEO who has experience at both clinical trials and manufacturing, so I find him to be an excellent choice. And September is almost here. What is that September Song? In my view we have patents at one end and trade secrets at the other...what do you think Don? Bookends.